NATACYN

This brand name is authorized in United States. It is also authorized in Hong Kong SAR China, Singapore.

Active ingredients

The drug NATACYN contains one active pharmaceutical ingredient (API):

1	Natamycin UNII 8O0C852CPO - NATAMYCIN
	Natamycin is a tetraene polyene antibiotic derived from Streptomyces natalensis. It possesses in vitro activity against a variety of yeast and filamentous fungi, including Candida, Aspergillus, Cephalosporium, Fusarium and Penicillium. The mechanism of action appears to be through binding of the molecule to the sterol moiety of the fungal cell membrane.
	Read more about Natamycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NATACYN Ophthalmic suspension, drops	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AA10	Natamycin	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	41714
SG	Health Sciences Authority	06719P
US	FDA, National Drug Code	0065-0645